earnings
confidence high
sentiment positive
materiality 0.75
GoodRx Q3 revenue $196M, net income $1.1M; raises manufacturer solutions outlook to ~35% growth
GoodRx Holdings, Inc.
2025-Q3 EPS reported
$0.07
revenue$602,068,000
- Revenue of $196.0M; net income $1.1M (0.6% margin).
- Adjusted EBITDA $66.3M (33.8% margin); Adjusted Net Income $28.8M (14.7% margin).
- Raises Pharma Manufacturer Solutions revenue growth outlook to ~35% YoY for FY2025; maintains total revenue and adjusted EBITDA guidance.
- Net cash from operations of $76.0M in Q3 2025.